Overview: Iron Studies Panel
Introduction: The Iron Studies Panel is a diagnostic tool designed to assess iron metabolism using serum samples. In India, iron deficiency anemia affects ~50-60 percent of women and children (higher in rural/low-SES due to poor diet, hookworm, malaria), while iron overload is rare but seen in thalassemia major. High morbidity from under-testing leading to delayed oral/parenteral iron or transfusion, causing fatigue, poor cognition, or heart failure in severe cases. Per hematology practices aligned with ICMR and National Iron Plus Initiative guidelines, the test employs spectrophotometry for serum iron, TIBC, ferritin, and transferrin saturation over 1-2 days with high accuracy, valuable for diagnosing iron deficiency vs anemia of chronic disease. This diagnostic falls under anemia screening and targets patients with microcytic anemia, fatigue, or high-risk groups (pregnant women, children), addressing accurate detection to guide iron supplementation and monitoring. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise iron status assessment and reducing anemia burden. Its serum-based approach ensures reliable iron profile.
Other Names: Iron Studies Pnl.
FDA Status: FDA approved, CLIA certified for biochemistry/hematology, compliant with 2025 standards.
Historical Milestone: Iron studies standard; in India, key in anemia control programs.
Purpose: The test assesses 3 parameters including serum iron to guide iron metabolism evaluation, diagnose deficiency/overload, inform supplementation.
Test Parameters: 1. Serum Iron, 2. TIBC, 3. Ferritin.
Pretest Condition: Fasting 10-12 hours recommended; patients should report fatigue or anemia symptoms.
Specimen: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.
Sample Stability at Room Temperature: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.
Sample Stability at Refrigeration: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.
Sample Stability at Frozen: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.
Medical History: Patients should provide details on diet, bleeding, chronic disease.
Consent: Written informed consent is required, detailing the test's purpose, potential risks of untreated iron deficiency including fatigue, benefits of assessment, and minimal discomfort from venipuncture.
Procedural Considerations: The test involves sample processing using spectrophotometry by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.
Factors Affecting Result Accuracy: Delays beyond stability periods, improper storage conditions, hemolysis, or recent iron intake can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.
Clinical Significance: Low ferritin/high TIBC indicates iron deficiency; high ferritin suggests overload/inflammation, necessitating specialist input.
Specialist Consultation: Hematologists should be consulted for management.
Additional Supporting Tests: CBC, peripheral smear for confirmation.
Test Limitations: Ferritin acute-phase reactant; comprehensive approach required.
References: Indian Journal of Hematology 2024, Anemia Studies India 2023.
